Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Government announces immediate ‘pause’ in use of vaginal mesh

  • Comment

The government and NHS have accepted a recommendation from the Independent Medicines and Medical Devices Safety Review to pause the use of vaginally inserted surgical mesh.

As a result, it said the use of vaginally inserted surgical mesh for stress urinary incontinence would be paused until a set of conditions to reduce the risk of injury were met.

“Our new approach will radically reduce the number of women have vaginal meshes inserted”

Lord O’Shaughnessy

Under the rules, they will only be used when there is no alternative and after “close and comprehensive” consultation between patient and clinician, with “rigorous oversight and governance at all times”.

The Independent Medicines and Medical Devices Safety Review made the interim recommendation following a programme of engagement with patients and patient groups.

The review was set up in February and is chaired by Baroness Julia Cumberlege. Its aim is to review what happened in each of the cases of primodos, sodium valproate and surgical mesh, including whether the processes pursued to date have been sufficient and satisfactory.

It also recommended that the pause should be extended to include vaginally inserted mesh to treat pelvic organ prolapse, and that the pause should be implemented through a high vigilance regime of restricted practice.

NHS England was now working with other health agencies to pause procedures quickly and safely, said the government.

In addition, a clinical advisory group has been established to ensure that appropriate measures are put in place to give effect to the high vigilance programme.

“We need to put in place a consistent, high quality service”

Jackie Doyle-Price

Meanwhile, NHS England and NHS Improvement have written to providers to ensure that provider medical directors and nurse directors are equipped with advice and guidance to ensure that clinicians can support patients to make clear decisions about their treatment.

Health minister Lord O’Shaughnessy said: “The department’s top priority is patient safety, and we have therefore immediately accepted Baroness Cumberlege’s recommendation.

“Our new approach, with a high vigilance programme of restricted practice, will radically reduce the number of women have vaginal meshes inserted, and ensure that when it does happen, it is only after close consultation with their clinician and with extremely thorough clinical oversight and governance,” he said.

Jackie Doyle-Price, mental health and inequalities minister, said: “We need to put in place a consistent, high quality service that meets the conditions set out by Baroness Cumberlege.

“Only then can women be confident when they are considering an operation to treat pelvic organ prolapse or stress urinary incontinence – conditions that cause not just physical discomfort but long lasting psychological effects,” she said.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.